在日本的血液透析患者中,PTH变异性与死亡风险增加有关
Tadashi Kato1, Kiryu Yoshida2, Maki Abe3
1Division of Nephrology, Department of Medicine, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa, Tokyo, 142-8555, Japan. t-k@med.showa-u.ac.jp.
Clinical and experimental nephrology
|October 7, 2025
概括
在血液透析患者中,在目标范围内保持副甲状腺激素 (PTH) 是至关重要的. 长时间的PTH偏差会增加死亡风险,尤其是在没有药物的情况下,这凸显了对二次性副甲状腺功能障碍症及时干预的需要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 临床医学 临床医学
背景情况:
- 副甲状腺激素 (PTH) 的升高与血液透析患者的不良结果有关.
- 这种人群中PTH水平波动对死亡率的影响尚不清楚.
研究的目的:
- 调查PTH的目标时间范围 (TTR) 与维护血液透析患者的死亡率之间的关联.
- 评估药理干预对这种关联的影响.
主要方法:
- 分析了315名血液透析患者,每年至少进行两次PTH测量.
- 患者根据PTH TTR进行分类:100%,75%-<100%,50%-<75%和<50%.
- 全因死亡率,心血管事件和骨折在4年内进行了评估.
主要成果:
- 与TTR<50%的患者相比,100%的PTH TTR患者的全因死亡率显著降低.
- 在没有治疗组中,较低的PTH TTR与增加的死亡率有关.
- 在接受药理干预的患者中,这种关联并不显著.
结论:
- 长时间偏离最佳PTH范围会增加血液透析患者的全因死亡率,特别是那些不服用药物的患者.
- 药理干预可以减轻与PTH可变性相关的死亡风险.
- 建议在PTH水平偏离目标范围时,对二次性甲状腺功能增强症进行早期干预.
相关概念视频
Hemodialysis II: Procedure and Complications
547
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
547
Hemodialysis III: Nursing Management
675
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
675
Hemodialysis I: Introduction
1.1K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.1K
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
453
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
453
Renal Failure: Dose Adjustments
396
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
396
Chronic Kidney Disease II: Clinical Manifestations
516
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
516


